pulmonary function on steady-state PbtO 2 during an oxygen challenge. In critically ill patients, end-organ oxygenation is often influenced by the ability of the lung to oxygenate arterial blood. To reach the brain, oxygen must diffuse from the alveolar air across the lung into the blood, and from the blood across the blood-brain barrier into the brain. A barrier to effective diffusion may occur either across the lung because of ventilation perfusion mismatch or across the blood-brain barrier due to cerebral factors.
The purpose of our study was to prospectively evaluate whether PbtO 2 during an oxygen challenge is influenced by noncerebral factors related to systemic oxygenation, such as PaO 2 , FiO 2 , and pulmonary function as represented by the PF ratio. Previous studies have proposed that the changes observed following an oxygen challenge might be related primarily to the brain's metabolic needs. Based on our clinical experience, we hypothesized that the PF ratio strongly influences PbtO 2 during an oxygen challenge and that this effect is mediated primarily through changes in arterial oxygen tension, rather than through exclusively cerebral factors.
Clinical Material and Methods

Patient Population
Thirty-seven consecutive patients admitted to San Francisco General Hospital with severe head injury defined as a Glasgow Coma Scale score Յ 8 or a head injury in combination with multisystem injury requiring ICP monitoring were included in this study. All patients with intracranial hematomas requiring removal underwent urgent surgical evacuation. Monitoring of ICP was performed using an external ventricular drain or an intraparenchymal ICP monitor (Camino, Integra Lifesciences). Patients were treated in accordance with standard guidelines for the management of severe TBI. 1 Clinical outcome was determined using the score on the GOS 6 months postinjury. This study was approved by the University of California, San Francisco, Committee for Human Research.
Brain Tissue Oxygen Monitoring
All patients underwent insertion of a Licox intraparenchymal brain tissue oxygen monitor (Integra Lifesciences) as part of the standard neurointensive care for patients with severe TBI at our institution. Monitors were inserted in patients in the ICU while they were intravenously sedated and after local anesthesia was induced (1% lidocaine). Licox probes were inserted over the Kocher point into the frontal lobe of the least injured hemisphere. Probes were allowed to stabilize for at least 12 hours following insertion before any oxygen challenge was performed. Follow-up computed tomography scans were obtained to confirm that the Licox probe was not in contused or infracted tissue.
Oxygen Challenge
At our institution, an oxygen challenge is performed daily as part of regular clinical care to evaluate the function and responsiveness of the brain tissue oxygen probe. The oxygen challenge involves increasing the FiO 2 concentration from baseline to 1.0 for ~ 20 minutes. The FiO 2 concentration is then returned to the prechallenge baseline level. An arterial blood gas is drawn just prior to initiating the oxygen challenge and at the end of the 20-minute challenge just before returning the FiO 2 concentration to baseline levels. Physiological variables, including PbtO 2 , ICP, systemic blood pressure, and percutaneous systemic oxygen saturation, are recorded at 1-minute intervals during the oxygen challenge. Chest radiographs are obtained at frequent intervals (usually daily) on all patients with intubation tubes as part of standard clinical care.
Statistical Analysis
Variables were expressed as means Ϯ SDs for continuous variables, median and interquartile range for ordinal categorical variables, or overall frequencies for nominal categorical variables as appropriate. The PF ratios were calculated as the ratio of PaO 2 to FiO 2 for these 2 time points as well. To compare current results with those reported previously in the literature, relative TOR during an oxygen challenge was calculated as described by van Santbrink and colleagues 19 using the following equation: relative TOR = (⌬ PbtO 2 / ⌬ PaO 2 ) / PbtO 2 (baseline) ϫ 100%.
In our study, several patients underwent multiple oxygen challenge tests at different points during their hospitalization. Because variables may show correlation between studies performed on the same subject, linear regression tends to overestimate the precision of results. Therefore, GEEs with robust standard errors were used to account for clustering of observations within individual patients. The GEEs were used to determine the primary relationship between the baseline PF ratio and PaO 2 or PbtO 2 during oxygen challenge, as well as in multivariable analyses to assess the influence of the PF ratio on PaO 2 or PbtO 2 during oxygen challenge. Primary and multivariable analysis with GEEs was also performed to assess the impact of relative TOR and the PF ratio on 6-month outcome. All statistical analyses were performed using Stata statistical software (version 8.0, Stata Corporation), and a probability value of Ͻ 0.05 was considered statistically significant.
Results
Sixty-nine oxygen challenges were performed in 37 consecutive patients with TBI. Patient characteristics are detailed in Table 1 . Mean FiO 2 , PF ratio, hemoglobin, MAP, ICP, CPP, PaO 2 , PaCO 2 , and PbtO 2 values before and after the oxygen challenge are detailed in Table 2 .
As expected, the baseline PF ratio was strongly correlated with postchallenge PaO 2 (r = 0.84, p Ͻ 0.0001; Fig. 1 ), indicating that patients with better pulmonary function attain higher arterial oxygen tension during an oxygen challenge. Each 50-point increase in the baseline PF ratio translated to a 26 mm Hg higher challenge PaO 2 (p Ͻ 0.001). This result is not surprising given that the response to an oxygen challenge is greatly dependent on the relative increase in FiO 2 concentration. Patients with poor baseline pulmonary function (PF ratio Յ 250) were ventilated at a mean FiO 2 of 0.54 Ϯ 0.13, whereas those with a PF ratio Ͼ 250 were ventilated at a mean FiO 2 of 0.40 Ϯ 0.09 to main-tain a goal of 100 mm Hg PaO 2 in all patients with TBI at our institution. At both baseline (r = 0.34, p Ͻ 0.005) and during oxygen challenge (r = 0.35, p Ͻ 0.005) PbtO 2 was associated with PaO 2 . Across the entire range of PaO 2 values (baseline and oxygen challenge), we observed a robust relationship between PbtO 2 and PaO 2 (r = 0.70, p Ͻ 0.001; Fig. 2 ), confirming the relationship between arterial oxygen tension and PbtO 2 reported in previous studies of humans and animals. 4, 7, 9, 13 As anticipated from the relationships between the PF ratio, PaO 2 , and PbtO 2 , we found a significant relationship between baseline PF ratio and challenge PbtO 2 (r = 0.41, p Ͻ 0.001). To further evaluate the effect of pulmonary status on brain tissue oxygenation, we compared baseline and challenge PbtO 2 in patients with a PF ratio Ͼ 250 with those patients with a PF ratio Յ 250 (Fig. 3) . At baseline, no significant difference in PbtO 2 was noted between patients with a PF ratio Ͼ 250 and those with a PF ratio Յ 250 (29.5 Ϯ 12.4 mm Hg and 29.6 Ϯ 12.8 mm Hg, respectively; p = 0.99). During the oxygen challenge, patients with a PF ratio Ͼ 250 attained a mean PbtO 2 of 97.8 Ϯ 45.6 mm Hg, compared with a mean PbtO 2 of 66.4 Ϯ 30.2 mm Hg in patients with a PF ratio Յ 250 (p Ͻ 0.005), implicating pulmonary status as an important influence on peak steady-state PbtO 2 attained with an oxygen challenge. There was no significant difference in mean hemoglobin level, MAP, ICP, CPP, or PaCO 2 between patients with a PF ratio Յ 250 compared with those with a PF ratio Ͼ 250, either at baseline or during oxygen challenge (Table 3) . Importantly, differences in pulmonary function appeared to influence the pattern of response of PbtO 2 to an oxygen challenge. Figure 4A demonstrates the pattern of the rise in brain tissue oxygen in a patient with severe TBI with a baseline PF ratio of 442 on the second hospital day (initial FiO 2 = 0.40). During the oxygen challenge, a brisk rise in PbtO 2 occurred over a course of ~ 6 minutes before reaching a plateau. This pattern is typical in patients with good * GSW = gunshot wound; LFU = lost to follow-up; MCA = motorcycle accident; MVA = motor vehicle accident; PVA = pedestrian vs. auto accident. pulmonary function. In contrast, an oxygen challenge performed in the same patient 2 days later at a similar baseline FiO 2 of 0.30, but a decreased baseline PF ratio of 223, revealed a markedly different pattern of response (Fig. 4B) . The magnitude of increase in PbtO 2 is blunted and occurs over a much longer time course of ~ 15-20 minutes. The change in response occurred concomitantly with the development of VAP in this patient, suggesting that the pattern of increase as well as the steady-state value of brain tissue oxygen following an oxygen challenge is influenced by pulmonary function.
Of the 37 patients in our series, VAP (as defined by the National Nosocomial Infection Surveillance criteria 10, 11 ) was diagnosed in 11 (30%) around the time of the oxygen challenge. Of these patients with VAP, 100% had a PF ratio Յ 250 at the time of diagnosis. Although a greater number of patients in our series (17 patients, 46%) had atelectasis on chest radiographs, only 4 of these patients (24%) had a PF ratio of Յ 250. Three patients who developed VAP had atelectasis that preceded the development of VAP. Two patients with VAP also met criteria for ARDS. Two patients also had significant pulmonary contusions from the initial injury in addition to VAP, and 1 patient had pulmonary contusions without other pulmonary disease also resulting in a PF ratio Յ 250. A pulmonary embolism was not diagnosed in any patient. Sixteen patients had a PF ratio Յ 250 during the time an oxygen challenge was performed. Several patients had worsening PF ratios and more blunted responses to an oxygen challenge during the course of the ICU hospitalization as pulmonary diseases developed.
Although the purpose of this study was to define the physiological relationship between lung function and PbtO 2 , 6-month outcome was also assessed. Thirteen (35.1%) of 37 patients had a favorable outcome, defined as a GOS score of 4-5, 6 months after injury. The overall mortality rate at 6 months was 18.9%. Two patients (5.4%) were lost to follow-up. There was no significant relationship between baseline PF ratio and outcome (p = 0.58). Given the previously published work of van Santbrink and associates, 19 we also calculated TOR in all our patients. In contrast to the results of van Santbrink and colleagues, we found no significant relationship between TOR and outcome (p = 0.99). Our smaller sample size, however, may not have been sufficiently powered to show a difference.
Discussion
Previous studies have demonstrated that low PbtO 2 is predictive of poor outcome after severe head trauma. Furthermore, investigators have suggested that this correlation is related to both the depth and duration of brain tissue hypoxia. 2, [16] [17] [18] Prevention and treatment of brain tissue hypoxia is now being strongly considered, and some investigative groups have already described their initial results with oxygen-directed therapy designed to maintain PbtO 2 above a certain threshold. 5, 14 Meixensberger and colleagues 5 used a CPP-directed strategy to maintain PbtO 2 Ͼ 10 mm Hg in 93 patients with severe TBI. Stiefel et al. 14 used a multifaceted protocol to maintain PbtO 2 Ͼ 25 mm Hg in 28 patients with severe TBI, comparing outcomes with those from historical controls. Although maintaining PbtO 2 above threshold levels is important, we believe that it is also imperative to identify the specific cause of low PbtO 2 in a given patient with TBI, as many systemic or cerebral factors may be responsible for a decline in cerebral oxygenation at a particular instance. Our data suggest that lower PbtO 2 values during an oxygen challenge may indicate primary pulmonary disease (such as atelectasis, pneumonia, or pulmonary contusion) that may require treatment itself. Pulmonary problems commonly occur in patients with TBI. In our series, 43% of patients had a PF ratio Յ 250 during the portion of the ICU course in which oxygen challenge was performed, which was due to VAP, severe atelectasis, pulmonary contusions, ARDS, or a combination of these conditions. In a prior study, acute lung injury occurred in 31% of patients with severe TBI and independently predicted a poorer outcome. 3 Notably, in a prior trial of cerebral blood flow-directed therapy in TBI, a 5-fold increase in the incidence of ARDS may have offset a beneficial effect of improved global cerebral oxygenation. 12 As oxygen-directed therapy is further evaluated for TBI, it will be necessary to consider patient pulmonary status when planning interventions to maximize brain tissue oxygenation, either as part of a clinical trial or for regular clinical care.
During neuromonitoring after severe brain injury, important information may be gained by challenging a physiological system. At our institution, as in many others, baseline PaO 2 is maintained at a level of ~ 100 mm Hg in patients with severe TBI. Patients with poor systemic oxygenation may be treated by increasing FiO 2 or the peak endexpiratory pressure to maintain this PaO 2 goal. When such interventions succeed in maintaining PaO 2 at a level of 1 00 mm Hg, PbtO 2 will often remain in the normal range, even in patients with poor pulmonary status. When an intervention such as an oxygen challenge is performed, the important influence of lung function on brain tissue oxygenation becomes evident. Our results suggest that those patients with better pulmonary status have higher PbtO 2 with an oxygen challenge than those with compromised pulmonary function (Fig. 3) . The peak PbtO 2 during an oxygen challenge is likely influenced by the peak PaO 2 during the challenge (Fig. 2) . Intuitively, it is understandable that those patients with better pulmonary function will have a higher PaO 2 level during an oxygen challenge compared with those patients with poor pulmonary function, and this may influence PbtO 2 in these patients. Our findings confirm this expected relationship and implicate pulmonary status as an important influence on peak PbtO 2 in an oxygen challenge.
Given that systemic oxygenation and brain tissue oxygenation are strongly linked through the relationships between oxygen transport through the lungs and to the brain, the care of patients with brain injury should rightly consider the interplay between both. Some investigative groups have proposed normobaric hyperoxia (an increase in FiO 2 to 1.0) as a treatment strategy to improve cerebral oxygenation in patients with severe TBI. 7, 15 Tolias and associates 15 studied the cerebral metabolic profile of 52 patients with severe TBI who underwent measurements with microdialysis. These investigators found a decrease in lactate, glutamate, and lactate/pyruvate ratio in patients treated with normobaric hyperoxia, compared with historical controls. Although the improved cerebral metabolic profile they describe may potentially benefit the injured brain, it is important to consider that in patients with pulmonary pathology, an increase in FiO 2 may not lead to the same degree of improved cerebral oxygenation. Our data suggest that patients with a low PF ratio will have a relatively lower
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Role of lung function in brain tissue oxygenation following TBI PbtO 2 at an FiO 2 of 1.0, implying that this treatment strategy may not be as effective in patients with TBI and severe pulmonary pathology.
In a prior study, van Santbrink and associates 19 described an association between TOR and 6-month GOS scores. In our study, we did not find a relationship between TOR and 6-month outcome scores. Although it is possible that our study was underpowered to detect this relationship, it may be that the response of the brain to an oxygen challenge as measured by TOR is not a particularly informative indicator of brain injury that predicts long-term functional disability. Additionally, van Santbrink and colleagues reported that different patterns of increase in PbtO 2 during oxygen challenge was predictive of outcome, but they did not describe the influence of pulmonary status (such as the PF ratio) on these PbtO 2 response patterns. Because the PF ratio strongly influences PbtO 2 during oxygen challenge, we are concerned that these patterns may primarily be indicators of the pulmonary status of the patient, rather than indicators of the brain's own ability to respond to an oxygen challenge (Fig. 4) . Certainly, we urge caution in using these patterns as a guide for neurological prognosis and believe that they may represent the complex interplay between the lung and brain. Because patients with TBI may suffer a primary injury to the chest wall and lung as part of their initial injury and are at risk for aspiration and VAP, it appears prudent to consider pulmonary status when interpreting results of a systemic oxygen challenge.
Our study has several limitations, including a small sample size for correlation with outcome. We did not set out to evaluate the relationship between PbtO 2 during an oxygen challenge and outcome, but rather to better define the physiological parameters leading to a poor response to an oxygen challenge. Nevertheless, future studies will need to address whether targeted treatment to improve low PbtO 2 by treating pulmonary diseases improves outcome in patients with severe TBI. An additional limitation of our study is that assessing the response to an oxygen challenge is inherently constrained by the ability to increase the FiO 2 to 1.0. This limits the ability to compare the absolute rise in PbtO 2 between patients with different baseline FiO 2 concentrations that may reflect their initial pulmonary status. Beginning the challenge at the same FiO 2 level regardless of pulmonary status may adversely affect patient care and was deemed imprudent by our group. Although it is not possible to compare absolute response to an oxygen challenge between patients due to the different baseline FiO 2 levels, the steady-state PbtO 2 during a challenge may be compared between patients, yielding potentially important information on the influence of pulmonary status on PbtO 2 . Lastly, our study did not systematically investigate the temporal relationship between the PF ratio and PbtO 2 throughout the ICU time course. We evaluated the relationship between the PF ratio, PaO 2 , and PbtO 2 at different time points after injury in our patients. Future studies may seek to study the temporal relationship between these variables. Better defining the interrelationships between pulmonary and cerebral variables influencing cerebral oxygenation may lead to effective targeted therapeutic strategies to prevent episodes of low PbtO 2 .
Conclusions
The PF ratio strongly influences PbtO 2 with an oxygen challenge in patients with severe TBI. In patients with TBI, a low PF ratio is associated with lower PbtO 2 during an oxygen challenge. Given that patients with severe TBI are at risk for pulmonary complications including pneumonia, severe atelectasis, and ARDS, pulmonary status should be considered when interpreting brain tissue oxygen.
